Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Some drugs used to treat immune conditions may cause different types of hair loss.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

The hair growth serum Trichosera® was effective in increasing hair regrowth and density and reducing hair fall without significant side effects.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

Griseofulvin is the best treatment for tinea capitis in children, but more research is needed on other treatments and safety.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

The congress concluded that misuse of antifungal drugs in South Asia has led to widespread treatment failure, and new approaches and regional cooperation are needed.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Hair growth serums A and C can affect hair growth genes and pathways, suggesting potential for personalized hair loss treatments.

HA-stimulated stem cell vesicles improved hair growth in male mice with androgenetic alopecia.

Many popular skincare products claim to prevent aging but lack strong evidence to prove their effectiveness and safety.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Experts agree on guidelines for safely using low-dose oral minoxidil to treat hair loss.

PRP treatment satisfies 58% of female hair loss patients, with most noticing fuller, thicker hair and less shedding.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Stem cell treatments can potentially treat baldness, with one trial showing hair growth after injecting a hair-stimulating complex, and no safety issues were reported.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.